Colchicine: A New Dawn for Preventing Complications After Heart Attack? Unveiling its Network Pharmacology and the COLD-MI Trial
DOI:
https://doi.org/10.5530/bems.10.2.7Keywords:
Myocardial infarction, Ischemia, Cardiology, Cardiac CareAbstract
Acute myocardial infarction, or heart attack, remains a significant cause of morbidity and mortality globally. Despite substantial advancements in acute management, the residual risk of recurrent coronary events, including myocardial infarction, stroke, and heart failure, poses a substantial challenge. This persistent threat underscores the imperative for ongoing research into novel therapeutic strategies to improve patient outcomes. The recently published COLD-MI trial results has generated significant interest by highlighting the potential of colchicine, a readily available and inexpensive medication, in preventing complications after a heart attack. This report delves into the rationale behind the COLD-MI trial, scrutinizes its findings, and explores the implications in correlation with network pharmacology of colchicine for future clinical practice.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.